Henri B. Kagan
Henri B. Kagan | |
|---|---|
| Born | 15 December 1930 Université Paris-Sud |
Henri Boris Kagan (born 15 December 1930) is currently an
asymmetric catalysis. His discoveries have had far-reaching impacts on the pharmaceutical industry.[1]
He graduated from the
catalysts
used in a variety of practical applications.
Honors
Dr Kagan is a member of the
2005 Benjamin Franklin Medal
.
In 2001 controversy was caused when Kagan was not given the
Monsanto Company in St Louis, Missouri, for work on catalytic asymmetric synthesis. It was thought that as Kagan was one of the pioneers of the field he too should have been honoured. However, as the prize can be given to a maximum of three people he was left off.[4]
References
- ISBN 978-0-900332-61-6.
- .
- ^ Frankin Laureate Citation Archived 2007-09-29 at the Wayback Machine
- PMID 11713488.
- Short biography of Kagan
- Henri B. Kagan; Olivier Riant (1992). "Catalytic asymmetric Diels Alder reactions". Chemical Reviews. 92 (5): 1007–1019. .
- P. Girard; J. L. Namy; H. B. Kagan (1980). "Divalent lanthanide derivatives in organic synthesis. 1. Mild preparation of samarium iodide and ytterbium iodide and their use as reducing or coupling agents". Journal of the American Chemical Society. 102 (8): 2693–2698. .
- H. B. Kagan; J. L. Namy (1986). "Lanthanides in organic synthesis". Tetrahedron. 42 (24): 6573–6614. .
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
